First Horizon Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9 | Hold |
1
| – | – | ﹤0.01% | 2313 |
|
2025
Q1 | $8 | Hold |
1
| – | – | ﹤0.01% | 2302 |
|
2024
Q4 | $5 | Hold |
1
| – | – | ﹤0.01% | 2267 |
|
2024
Q3 | $7 | Hold |
1
| – | – | ﹤0.01% | 2308 |
|
2024
Q2 | $11 | Hold |
1
| – | – | ﹤0.01% | 2277 |
|
2024
Q1 | $19 | Hold |
1
| – | – | ﹤0.01% | 2283 |
|
2023
Q4 | $22 | Hold |
1
| – | – | ﹤0.01% | 2356 |
|
2023
Q3 | $21 | Hold |
1
| – | – | ﹤0.01% | 2378 |
|
2023
Q2 | $47 | Hold |
1
| – | – | ﹤0.01% | 2433 |
|
2023
Q1 | $42 | Hold |
1
| – | – | ﹤0.01% | 2447 |
|
2022
Q4 | $38 | Hold |
1
| – | – | ﹤0.01% | 2439 |
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2430 |
|
2022
Q2 | $0 | Sell |
1
-14
| -93% | – | ﹤0.01% | 2520 |
|
2022
Q1 | $0 | Sell |
15
-37
| -71% | – | ﹤0.01% | 2196 |
|
2021
Q4 | $2K | Hold |
52
| – | – | ﹤0.01% | 2004 |
|
2021
Q3 | $2K | Buy |
52
+33
| +174% | +$1.27K | ﹤0.01% | 2014 |
|
2021
Q2 | $1K | Buy |
19
+9
| +90% | +$474 | ﹤0.01% | 1906 |
|
2021
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1982 |
|
2020
Q1 | – | Sell |
-226
| Closed | -$16K | – | 1547 |
|
2019
Q4 | $16K | Hold |
226
| – | – | ﹤0.01% | 949 |
|
2019
Q3 | $31K | Hold |
226
| – | – | ﹤0.01% | 692 |
|
2019
Q2 | $40K | Hold |
226
| – | – | ﹤0.01% | 631 |
|
2019
Q1 | $35K | Buy |
226
+46
| +26% | +$7.12K | ﹤0.01% | 618 |
|
2018
Q4 | $17K | Hold |
180
| – | – | ﹤0.01% | 859 |
|
2018
Q3 | $24K | Hold |
180
| – | – | ﹤0.01% | 821 |
|
2018
Q2 | $27K | Buy |
180
+124
| +221% | +$18.6K | ﹤0.01% | 792 |
|
2018
Q1 | $8K | Buy |
+56
| New | +$8K | ﹤0.01% | 1077 |
|